Scolaris Content Display Scolaris Content Display

Endoluminal stents for iliac and infrainguinal arterial disease

Referencias

Additional references

Ir a:

Atkins 2004

Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490‐4.

Bekken 2015

Bekken J, Jongsma H, Ayez N, Hoogewerf CJ, Van Weel V, Fioole B. Angioplasty versus stenting for iliac artery lesions. Cochrane Database of Systematic Reviews 2015, Issue 5. [DOI: 10.1002/14651858.CD007561.pub2]

Bosiers 2012

Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, et al. Randomized comparison of everolimus‐eluting versus bare‐metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. Journal of Vascular Surgery 2012;55(2):390‐8.

Cejna 2001

Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. Journal of Vascular and Interventional Radiology 2001;12(1):23‐31.

Chowdhury 2014

Chowdhury MM, McLain AD, Twine CP. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD006767.pub3]

Criqui 2015

Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation Research 2015;116(9):1509‐26.

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.

Dormandy 1994

Dormandy J, Belcher G, Broos P, Eikelboom B, Laszlo G, Konrad P, et al. Prospective study of 713 below‐knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. British Journal of Surgery 1994;81(1):33‐7.

Dormandy 2000

Dormandy JA, Rutherford RB. Management of peripheral arterial disease. Journal of Vascular Surgery 2000;31(1, Pt 2):S1‐S296.

Duda 2005

Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus‐eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. Journal of Vascular and Interventional Radiology 2005;16(3):331‐8.

Duffy 2015

Duffy JMN, Rolph R, Waltham M. Stent graft types for endovascular repair of abdominal aortic aneurysms. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD008447.pub3]

ESO 2011

European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European Heart Journal 2011;32(22):2851‐906.

Fontaine 1954

Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders [Die chirugische Behandlung der peripheren Durchblutungsstörungen]. Helvetica Chirurgica Acta 1954;21(5/6):499‐533.

Fowkes 1991

Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology 1991;20(2):384‐92.

Fowkes 2008

Fowkes F, Leng GC. Bypass surgery for chronic lower limb ischaemia. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002000.pub2]

Fowkes 2013

Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382(9901):1329‐40.

Grimm 2001

Grimm J, Muller‐Hulsbeck, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. Journal of Vascular and Interventional Radiology 2001;12(8):935‐41.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hsu 2011

Hsu CCT, Rophael JA, Mofidi R, Kwan GNC, van Driel ML. Percutaneous transluminal arterial angioplasty versus stenting for infrapopliteal arterial lesions in critical limb ischaemia. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009195]

Jaff 2015

Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below‐the‐knee arteries: a supplement to the Inter‐Society Consensus for the management of peripheral arterial disease (TASC II). Journal Endovascular Therapy 2015;22(5):663‐77.

Lane 2014

Lane R, Ellis B, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858.CD000990.pub3]

Rastan 2012

Rastan A, Brechtel K, Krankenberg H, Zahorsky R, Tepe G, Noory E, et al. Sirolimus‐eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare‐metal stents: long‐term results from a randomized trial. Journal of the American College of Cardiology 2012;60(7):587‐91.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rolph 2015

Rolph R, Duffy JMN, Waltham M. Stent graft types for endovascular repair of thoracic aortic aneurysms. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD008448.pub3]

Rutherford 1997

Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. Journal of Vascular Surgery 1997;26(3):517‐38.

Schillinger 2006

Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New England Journal of Medicine 2006;354(18):1879‐88.

Selvin 2004

Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999‐2000. Circulation 2004;110(6):738‐43.

Vroegindeweij 1997

Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovascular and Interventional Radiology 1997;20(6):420‐5.

References to other published versions of this review

Ir a:

Chua 2007

Chua B, Robless P, Stansby GP. Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006644]
Table 1. Example 'Summary of findings' table

Bare metal stent compared with covered stent for restoration of patency in iliac artery occlusion or stenosis

Patient or population: people with iliac artery occlusion or stenosis

Settings: hospital

Intervention: bare metal stent

Comparison: covered stent

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Covered stent

Bare metal stent

Primary unassisted vessel patency failure

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Primary assisted patency

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Secondary patency

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Quality of life parameter

[range of scale or scale description]

[follow‐up]

The mean quality of life parameter ranged across control groups from
[value][measure]

The mean quality of life parameter in the intervention groups was
[value] [lower/higher]
[(value to value lower/higher)]

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

*The basis for the assumed risk is the average risk in the covered stent group (i.e. the number of participants with events divided by total number of participants of the covered stent group included in the meta‐analysis). The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Table 1. Example 'Summary of findings' table
Ir a la tabla del protocolo